Biventricular unloading in patients with refractory cardiogenic shock

Area of Science:

• Cardiology
• Critical Care Medicine
• Mechanical Circulatory Support

Background:

• Refractory cardiogenic shock (RCS) presents a significant clinical challenge with high mortality.
• Mechanical circulatory support (MCS) devices offer expanded therapeutic options for RCS patients.
• Biventricular unloading strategies are increasingly explored for severe cardiac dysfunction.

Purpose of the Study:

• To evaluate the feasibility and outcomes of biventricular unloading using Impella-2.5 and VA-ECMO in patients with RCS.
• To assess the impact of this combined support strategy on hemodynamic parameters and survival.
• To compare observed mortality rates with predicted outcomes in a high-risk patient cohort.

Main Methods:

• A retrospective analysis of consecutive patients with RCS requiring biventricular unloading with Impella-2.5 and VA-ECMO.
• Data collection included demographics, etiology of RCS, severity scores (SAPS II, SOFA), and in-hospital outcomes.
• Key outcome measures were survival to discharge, bridging to Ventricular Assist Device (VAD) implantation, and 28-day mortality.

Main Results:

• The study included 17 patients (mean age 63.3 years, 88% male) with RCS, predominantly due to acute myocardial infarction (82%).
• Biventricular support led to significant reductions in vasopressor doses (norepinephrine, p=0.025) and lactate levels (p=0.005) within 72 hours.
• Overall 28-day survival was 41%, with 5 patients (29%) successfully weaned and discharged, and 3 (18%) bridged to VAD.

Conclusions:

• Biventricular support with Impella-2.5 and VA-ECMO is a feasible strategy for managing refractory cardiogenic shock.
• This combined approach achieves significant hemodynamic stabilization and lactate clearance.
• Despite high severity scores, the observed ICU and 28-day mortality rates were favorable compared to predictions.